ADHD in the News 2022-12-01

Adderall shortage raises questions about widespread dependency on the drug

There is a national shortage of Adderall, a drug used to treat several attention-deficit disorders. Intermittent manufacturing delays and a lack of supply to meet market demand in the U.S. left those who rely on the drug unsure about how they'll be able to get the medication they say they need to function. Dr. Craig Surman joined William Brangham to discuss the shortage.

Listen on Apple Podcasts:

How to Tell the Difference Between Regular Distraction and A.D.H.D.

Everyone has bouts of distraction and forgetfulness. Here’s when psychiatrists diagnose it as something clinical.

Concerns grow over online ADHD diagnoses

Approximately 10 million adults have attention-deficit/hyperactivity disorder (ADHD), according to CHADD, a respected ADHD organization founded in 1987. Now, some telemedicine services which advertise an easy path to get evaluated for a possible ADHD diagnosis and obtain a prescription, completely virtually, have entered the landscape and some experts and authorities are taking a closer look.

Simulated driving program reduces crash risk for teens with ADHD in small study

A program that combines computer-based and driving simulator training may reduce the proportion of crashes and near crashes among teens with attention-deficit/hyperactivity disorder (ADHD), according to a small study funded by the National Institutes of Health.

NIH researchers unlock pattern of gene activity for ADHD

Researchers at the National Institutes of Health have successfully identified differences in gene activity in the brains of people with attention deficit hyperactivity disorder (ADHD). The study, led by scientists at the National Human Genome Research Institute (NHGRI), part of NIH, found that individuals diagnosed with ADHD had differences in genes that code for known chemicals that brain cells use to communicate.

Benzodiazepine exposure in pregnancy does not up risk for ADHD, autism

Benzodiazepine exposure during pregnancy seems not to be associated with increased risks for development of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), according to a study published online Nov. 22 in JAMA Network Open.

Methylphenidate Improves Functionality in Preschoolers With ADHD

KEY POINT: Methylphenidate is well tolerated and effective in reducing the frequency and severity of ADHD symptoms and improving global functioning. Functionality among preschoolers with attention-deficit/hyperactivity disorder (ADHD) improves with 8 weeks of methylphenidate therapy, according to study results published in The Lancet Child & Adolescent Health.

Brain MRI Finds Areas of Interest in Kids With ADHD — Findings could potentially offer a more objective diagnosis for the disorder, researcher says

CHICAGO -- Children diagnosed with attention deficit-hyperactivity disorder (ADHD) appear to have brain abnormalities that can be observed with MRI, findings that may allow for a more objective diagnosis of the disorder, a researcher suggested here. After analyzing MRI scans of almost 8,000 children, investigators observed abnormal connectivity in the brain networks involved in memory processing and auditory processing among those with ADHD, said Huang Lin, PhD, a postgraduate fellow at the Yale School of Medicine in New Haven, Connecticut.

Young Motherhood, Child ADHD Link Explained

There are several factors, mostly involving socioeconomic disadvantages, increase the risk of young mothers giving birth to children with attention deficit/hyperactivity disorder (ADHD).

Teens and young adults are self-diagnosing mental illness on TikTok. What could go wrong?

The role of social media in the mental health space has grown as the country’s intense mental health crisis meets a shortage of mental health providers.

Amid the Adderall Shortage, People With A.D.H.D. Face Withdrawal and Despair

Without medication, patients are wondering what comes next.

ADHD medication for amphetamine addiction linked to reduced risk of hospitalization and death, study finds

The ADHD medication lisdexamfetamine was associated with the lowest risk of hospitalization and death in people with amphetamine addiction, when medications generally used among persons with substance use disorders were compared, according to a new study.

Meta-Analysis Finds ADHD Drugs Not Linked to Risk of Cardiovascular Disease — Still, authors say more research needed to rule out risk in certain groups

Use of medications for attention deficit-hyperactivity disorder (ADHD) was not associated with increased cardiovascular disease (CVD) risk, a systematic review and meta-analysis of 19 studies showed, although the researchers cautioned that a modest risk increase could not be completely ruled out.